Joel Isaacson & Co., LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1599330
NEW YORK, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$285,619
+$59,670 QoQ
Shares Held
575
+13.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,259
of 1,745 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Joel Isaacson & Co., LLC holds $3,465,389 across 6 Biotechnology names. VRTX ranks #3 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,067 | $1,912,397 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
10,247 | $802,032 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
575 | $285,619 | |
| 4 | EDIT |
Editas Medicine, Inc.
|
68,144 | $220,786 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
25,000 | $218,875 | |
| 6 | CGEN |
Compugen Ltd
|
12,000 | $25,680 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,619 | 575 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $225,949 | 506 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $223,053 | 492 | Shares | Sole | 2026-01-30 | |
| 2025-06-30 | $202,120 | 454 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $220,108 | 454 | Shares | Sole | 2025-04-25 | |
| 2024-06-30 | $219,829 | 469 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||